OriGene Antibodies in recent publications
Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
View All Citations >>
Home All anti-GBP1 antibodies
Anti-GBP1 Antibody EPR8285
Also for GBP1 (NM_002053)
Homo sapiens guanylate binding protein 1, interferon-inducible (GBP1)
67kD;OTTHUMP00000012352; guanylate binding protein 1, interferon-inducible, 67kDa
A synthetic peptide corresponding to residues in human GBP1 was used as an immunogen.
Store at -20 °C. Buffer: Antibody buffer, sodium azide, glycerol, and BSA. Stable for 12 months from date of receipt.
WB, IHC, IF
WB: 1:1,000 - 10,000; IHC 1:100 - 250; ICC: 1:250 - 500;
Guanylate binding protein expression is induced by interferon. Guanylate binding proteins such as GBP1 are characterized by their ability to specifically bind guanine nucleotides (GMP, GDP, and GTP) and are distinguished from the GTP-binding proteins by the presence of 2 binding motifs rather than 3 (1).
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
Western blot analysis on (A) HeLa treated with IFN-gamma and (B) HeLa cell lysates using anti-GBP1 RabMAb.
Immunohistochemical analysis of paraffin-embedded human spleen tissue using anti-GBP1 RabMAb.
Immunofluorescent staining of IFN-gamma induced HeLa cells using anti-GBP1 RabMAb.